Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesOrthopedics/MusculoskeletalPacificSource Bone Growth Coverage | OpenPayer
    Ask Trek AI about this page
    CurrentPacificSource Community SolutionsPolicy N/A

    Bone Growth (Electronic and Ultrasonic) Stimulators

    Customize your policy alerts

    Sign up for all pacificsourcecommunitysolutions policy alerts

    Know when pacificsourcecommunitysolutions releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Coverage of electronic and ultrasonic bone growth stimulators for Commercial, Medicare, and Medicaid members in Idaho, Montana, Oregon, and Washington, subject to applicable clinical criteria, regulatory requirements, and member benefit terms.

    Policy Summary
    PayerPacificSource Community Solutions
    PolicyBone Growth (Electronic and Ultrasonic) Stimulators
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateNovember 1, 2020
    Next Review DateJune 1, 2027
    Key ActionDocument the device type, intended treatment area, and FDA approval for that intended use.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    4Applicable states
    3Covered lines of business
    1 cmMaximum fracture gap

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    3 monthsMinimum time since fracture
    5Listed procedure and device codes
    20979Medicaid insufficient-evidence code

    Coverage Criteria

    Commercial non-invasive electrical spinal stimulation

    Commercial coverage: non-invasive electrical bone stimulation for spinal surgery is medically necessary when the Carelon Musculoskeletal Spine Surgery Guideline criteria are met.

    Non-invasive spinal stimulation: Non-invasive electrical bone stimulation is used for spinal surgery and all criteria outlined in the Carelon Musculoskeletal Spine Surgery Guideline are met.

    External guideline criteria apply.

    Commercial invasive electrical stimulation for lumbar fusion

    Commercial coverage: invasive electrical bone stimulation for spinal surgery is medically necessary when ALL of the following criteria are met.

    Treatment indication: The stimulator is used as an adjunct to lumbar, non-cervical spinal fusion to prevent fusion failure.

    ONE or more risk factors for failed fusion

    • Previously failed lumbar spinal fusion(s).
    • Grade III or higher spondylolisthesis.Grade III or higher
    • Fusion is to be performed at more than one level.More than one level
    • The patient is a current smoker.
    • The patient has diabetes.
    • The patient has renal disease.
    • The patient has a history of or high risk for malnutrition.

    Commercial fracture non-union or congenital pseudoarthrosis

    Commercial coverage: invasive, non-invasive, or semi-invasive electrical bone stimulators are medically necessary for fracture non-union or congenital pseudoarthrosis when ALL of the following criteria are met.

    Diagnosis: The patient has a fracture non-union or congenital pseudoarthrosis.
    Time since fracture: At least 3 months have passed since the date of fracture.At least 3 months
    Imaging evidence: Radiologic imaging obtained at least 90 days from the date of fracture confirms that healing has not progressed.At least 90 days from date of fracture
    Fracture gap: The fracture gap is one centimeter or less.

    Commercial ultrasonic bone growth stimulation

    Commercial coverage: ultrasonic bone growth stimulators are medically necessary when ALL criteria in MCG ACG A-0414, Bone Growth Stimulator, Ultrasonic, are met.

    MCG ultrasonic criteria: All criteria outlined in MCG ACG: A-0414, Bone Growth Stimulator, Ultrasonic, are met.

    External MCG criteria apply.

    Medicaid coverage

    Medicaid coverage is subject to applicable Oregon administrative rules, benefit limitations and exclusions, HERC guidance, and NCD requirements.

    Noninvasive electrical or ultrasonic stimulation: Noninvasive electrical osteogenesis stimulators (E0747) and noninvasive ultrasonic osteogenesis stimulators may be covered when the criteria in OAR 410-122-0510 are met.OAR 410-122-0510 criteria

    Coverage also follows the general coverage, limitations, and exclusions in OAR 410-141-3820, OAR 410-141-3825, OAR 410-120-1200, and HERC Excluded Services Guideline Note E2.

    Implanted electrical stimulation: Surgically implanted electrical osteogenesis stimulators (E0749) are covered under the requirements of NCD 150.2.NCD 150.2 criteria
    EPSDT beneficiaries: For EPSDT beneficiaries, the determination follows EPSDT coverage requirements and includes an individual review of medical necessity and medical appropriateness before coverage is denied.

    Medicare coverage

    Medicare coverage follows NCD 150.2 for osteogenesis stimulators.

    NCD 150.2 requirements: The requested osteogenesis stimulator meets the applicable coverage requirements of NCD 150.2.NCD 150.2 criteria

    An ultrasonic osteogenesis stimulator is not medically necessary when used with another noninvasive osteogenesis stimulator.

    For Medicare, an ultrasonic osteogenesis stimulator is excluded as not medically necessary when it is used with another noninvasive osteogenesis stimulator.

    For Medicaid, noninvasive low-intensity ultrasound stimulation to aid bone healing, coded 20979, is considered to have insufficient evidence of effectiveness under HERC Excluded Services Guideline Note E2.

    For Medicare, an ultrasonic osteogenesis stimulator is not medically necessary when it is used with another noninvasive osteogenesis stimulator.

    Coding Information

    Coding Informationmixed
    20975Electrical stimulation to aid bone healing; invasive (operative)
    20979Low intensity ultrasound stimulation to aid bone healing, noninvasive (non-operative)
    E0747Osteogenesis stimulator, electrical, noninvasive, other than spinal applications
    E0749Osteogenesis stimulator, electrical, surgically implanted
    E0760Osteogenesis stimulator, low intensity ultrasound, non-invasive
    Time Since Fracture
    Minimum time since fractureAt least 3 months
    Applies toCommercial treatment of fracture non-union or congenital pseudoarthrosis
    Required documentationThe date of fracture must be documented
    Radiologic Imaging Interval
    Minimum intervalAt least 90 days from the date of fracture
    Required evidenceRadiologic imaging must confirm that healing has not progressed
    Applies to

    Provider Documentation and Action Items

    Documentation Required

    Device and FDA Approval Documentation

    Document the requested bone growth stimulator’s device type and intended treatment area, and verify that the device is FDA approved for that area of intended use.

    • Identify whether the device is non-invasive electronic, semi-invasive electronic, invasive electronic, or ultrasonic.
    • Specify the intended treatment area and clinical use.
    Documentation Required

    Lumbar Fusion Risk Factors

    For an invasive electrical bone stimulator used in spinal surgery, document that it is an adjunct to a non-cervical lumbar spinal fusion to prevent fusion failure and that at least one qualifying risk factor is present.

    • Previously failed lumbar spinal fusion(s).
    • Grade III or higher spondylolisthesis.
    • Fusion at more than one level.
    • Current smoker.

    Background

    Electronic and ultrasonic bone growth stimulators are used to promote bone healing in fractures, bone grafting procedures, and selected spinal fusion settings. Electronic devices may be non-invasive, semi-invasive, or invasive; ultrasonic devices use low-intensity pulsed ultrasound to accelerate healing of fractures or osteotomies. Coverage criteria vary according to the device type and the member’s line of business.

    Definitions

    Failed Spinal Fusion
    DefinitionFailure to achieve solid bony fusion at least 6 months after the index spinal fusion surgery
    Radiographic evidenceLack of radiographic progression on serial imaging obtained at least 90 days apart
    Fusion-site findingAbsence of bridging bone at the intended fusion site
    Non-Invasive Electronic Bone Growth Stimulator
    PlacementExternally placed devices
    Included technologyPulsed electromagnetic fields
    Other included technologies
    Policy Summary
    PayerPacificSource Community Solutions
    PolicyBone Growth (Electronic and Ultrasonic) Stimulators
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateNovember 1, 2020
    Next Review DateJune 1, 2027
    Key ActionDocument the device type, intended treatment area, and FDA approval for that intended use.
    SourceLink
    On This Page
    Coverage CriteriaCoding InformationProvider Documentation and Action ItemsBackgroundDefinitions
    1 centimeter or less
    Immobilization and compliance: The patient can be adequately immobilized and is likely to comply with non-weight bearing.
    OAR 410-151-0000 through 410-151-0003

    Relevant guidance, including OAR 410-122-0510 and HERC Excluded Services Guideline Note E2, may inform the individual case review.

    Commercial fracture non-union or congenital pseudoarthrosis treatment
    Fracture Gap
    Maximum fracture gapOne centimeter or less
    Measurement applies toThe fracture gap
    Applies toCommercial fracture non-union or congenital pseudoarthrosis treatment
    Lumbar Fusion Level
    Qualifying levelFusion performed at more than one level
    Risk factorMultilevel fusion is a qualifying risk factor for failed fusion
    Applicable procedureAdjunct lumbar, non-cervical spinal fusion
    Failed Spinal Fusion Interval
    Minimum interval after index surgeryAt least 6 months after index spinal fusion surgery
    Serial imaging intervalImaging must be obtained at least 90 days apart
    Required imaging findingLack of radiographic progression of fusion
  1. Diabetes.
  2. Renal disease.
  3. History of or high risk for malnutrition.
  4. Documentation Required

    Fracture Non-Union Documentation

    For treatment of a fracture non-union or congenital pseudoarthrosis, submit documentation establishing every required criterion.

    • Diagnosis of fracture non-union or congenital pseudoarthrosis.
    • At least 3 months have passed since the fracture date.
    • Radiologic imaging performed at least 90 days after the fracture date confirms that healing has not progressed.
    • Fracture gap is 1 centimeter or less.
    • Patient can be adequately immobilized and is likely to comply with non-weight-bearing requirements.

    Unsupported block type: prior_auth strong

    Denial Risk

    FDA Approval Required

    The requested bone growth stimulator must be FDA approved for the intended area of use.

    • Requests for devices lacking FDA approval for the intended treatment area do not meet this requirement.
    Denial Risk

    Lumbar Fusion Criteria Not Met

    Commercial invasive electrical stimulation for spinal surgery may be denied when the request is not for an adjunct non-cervical lumbar fusion to prevent fusion failure or when none of the required qualifying risk factors is documented.

    • At least one qualifying risk factor must be present: previously failed lumbar fusion, Grade III or higher spondylolisthesis, multilevel fusion, current smoking, diabetes, renal disease, or history/high risk of malnutrition.
    Denial Risk

    Non-Union Criteria Not Met

    Commercial invasive, non-invasive, or semi-invasive electrical stimulation for fracture non-union or congenital pseudoarthrosis may be denied when all required criteria are not satisfied.

    • Required criteria include the diagnosis, at least 3 months since fracture, imaging at least 90 days after fracture showing no healing progress, fracture gap of 1 centimeter or less, and ability and likelihood to comply with immobilization and non-weight-bearing.
    Billing Rule

    Medicaid Code 20979 Billing Rule

    For Medicaid, noninvasive low-intensity ultrasound stimulation to aid bone healing billed under code 20979 is considered to have insufficient evidence of effectiveness under HERC Prioritized List Excluded Services Guideline Note E2.

    • Code 20979 may be denied or treated as insufficient evidence under the applicable Medicaid coverage rules.
    • EPSDT beneficiaries require the individual case review described in the EPSDT requirements before denial.
    Denial Risk

    Concurrent Noninvasive Stimulators

    Under Medicare, an ultrasonic osteogenesis stimulator is denied as not medically necessary when used concurrently with another noninvasive osteogenesis stimulator.

    • The exclusion applies to concurrent use with another noninvasive osteogenesis stimulator.
    Direct current capacitive coupling or combined electromagnetic field technology
    Semi-Invasive Electronic Bone Growth Stimulator
    Electrical technologyDirect-current electrical stimulation
    Lead configurationPercutaneous cathode and anode leads
    Lead placementLeads are placed through the skin at the treatment site
    Invasive Electronic Bone Growth Stimulator
    Device typeImplanted direct-current device
    Covered use contextsAdjunct to non-cervical spinal (lumbar) fusion or treatment of non-union fractures
    Power sourceRemoved in a second surgical procedure when stimulation is completed
    Ultrasonic Bone Growth Stimulator
    TechnologyLow-intensity pulsed ultrasound
    Intended applicationUsed to accelerate healing of fractures or osteotomies
    Device categoryUltrasonic bone growth stimulator